Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global AAV Vector Manufacturing Market Gearing Up for Outstanding Expansion at a CAGR of ~22% by 2034 | DelveInsight

globenewswire.com
PFE Mentioned as a key company in the Adeno-Associated Virus Vectors in Gene Therapy Market and Gene Therapy Market, indicating involvement in the growing AAV vector manufacturing sector. CSL Listed as a key company in the Adeno-Associated Virus Vectors in Gene Therapy Market, suggesting its role in the expanding AAV vector manufacturing field. AMTX Mentioned as a key company in the Adeno-Associated Virus Vectors in Gene Therapy Market, indicating its involvement in the expanding AAV vector manufacturing sector. JNJ Identified as a key company in the Gene Therapy Market, suggesting its participation in the broader gene therapy and AAV vector manufacturing space. SLDB Identified as a key company in the Gene Therapy Market, suggesting its participation in the growth of AAV vector manufacturing. QURE Mentioned as a key company in the Gene Therapy Market, suggesting its participation in the growth of AAV vector manufacturing. TMO Listed as a key company in the Cell and Gene Therapy Manufacturing Market, indicating its involvement in the expanding AAV vector manufacturing sector. CRL Mentioned as a key company in the Cell and Gene Therapy Manufacturing Market, suggesting its participation in the growth of AAV vector manufacturing. MRK Listed as a key company in the Cell and Gene Therapy Manufacturing Market, suggesting its role in the growth of AAV vector manufacturing. TAK Mentioned as a key company in the Cell and Gene Therapy Manufacturing Market, indicating its involvement in the expanding AAV vector manufacturing sector.

Global AAV Vector Manufacturing Market Gearing Up for Outstanding Expansion at a CAGR of ~22% by 2034 | DelveInsight New York, USA, April 28, 2026 (GLOBE NEWSWIRE) -- Global AAV Vector Manufacturing Market Gearing Up for Outstanding Expansion at a CAGR of ~22% by 2034 | DelveInsight

The AAV vector manufacturing market is mainly fueled by the expanding landscape of gene therapy research and development, as AAV vectors are extensively utilized for therapeutic gene delivery because of their strong safety profile and ability to provide sustained gene expression. The growing incidence of genetic and rare disorders, including hemophilia, spinal muscular atrophy, and Duchenne muscular dystrophy, is also boosting the need for AAV-based treatments. Moreover, the increasing number of gene therapy clinical studies, rising investments in biotechnology and viral vector production infrastructure, along with ongoing advancements in manufacturing and purification technologies, are playing a major role in driving market expansion.

DelveInsight’s AAV Vector Manufacturing Market Insights report provides the current and forecast market analysis, individual leading AAV vector manufacturing companies’ market shares, challenges, AAV vector manufacturing market drivers, barriers, trends, and key AAV vector manufacturing companies in the market.

AAV Vector Manufacturing Market Summary

To read more about the latest highlights related to the AAV vector manufacturing market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/adeno-associated-virus-aav-vector-manufacturing-market

Key Factors Contributing to the Rise in Growth of the AAV Vector Manufacturing Market

Get a sneak peek at the AAV vector manufacturing market dynamics @ AAV Vector Manufacturing Market Trends

Regional AAV Vector Manufacturing Market Insights

North America

Europe

Asia-Pacific

To know more about why North America is leading the market growth in the AAV vector manufacturing market, get a snapshot of the AAV Vector Manufacturing Market Share

Recent Developmental Activities in the AAV Vector Manufacturing Market

What is AAV Vector Manufacturing?

AAV vector manufacturing refers to the complex bioprocess used to produce AAV vectors, which are widely utilized as delivery vehicles in gene therapy for transferring therapeutic genes into target cells. The manufacturing process typically involves upstream production, where host cells such as HEK293 or insect cells are engineered through transfection or infection to generate recombinant AAV particles, followed by downstream purification steps including filtration, chromatography, and ultracentrifugation to isolate high-purity vectors. Critical quality control measures are then applied to assess potency, purity, genome integrity, and safety before clinical or commercial use. As demand for gene therapies rises, AAV vector manufacturing has become a key focus area for biopharmaceutical companies, driving innovation in scalable production platforms, process optimization, and regulatory-compliant manufacturing systems.

AAV Vector Manufacturing Market Assessment

Which MedTech key players in the AAV vector manufacturing market are set to emerge as the trendsetter explore @ AAV Vector Manufacturing Market Analysis

Table of Contents

Interested in knowing the AAV vector manufacturing market share by 2034? Click to get a snapshot of the AAV Vector Manufacturing Market Size

Related Reports

Adeno-Associated Virus Vectors in Gene Therapy Market

Adeno-Associated Virus Vectors in Gene Therapy Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key adeno-associated virus vectors in gene therapy companies, including Pfizer, CSL Behring, Spark Therapeutics, Freeline Therapeutics, RegenxBio, Amicus Therapeutics, and others.

Adeno-Associated Virus Vectors in Gene Therapy Clinical Trial Analysis

Adeno-Associated Virus Vectors in Gene Therapy Pipeline Insight – 2026 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key adeno-associated virus vectors in gene therapy companies, including Pfizer, CSL Behring, Spark Therapeutics, Freeline Therapeutics, RegenxBio, Amicus Therapeutics, and others.

Gene Therapy Market

Gene Therapy Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key gene therapy companies, including Abiomed, Inc., Asahi Kasei Corporation, Abbott Laboratories, Berlin Heart GmbH, Jarvik Heart, Inc., Medtronic Plc., Terumo Corporation, Evaheart, Inc., Calon Cardio, SynCardia Systems LLC, Cardiobridge GmbH, LivaNova, Inc., Cirtec, CorWave SA, FineHeart, ReliantHeart Inc., and others.

Gene Therapy Competitive Landscape

Gene Therapy Competitive Landscape – 2026 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key gene therapy companies, including Novartis, Johnson & Johnson, Fibrocell Technologies, Pfizer, HELIXMITH Co., Ltd., Sarepta Therapeutics, REGENXBIO, Solid Biosciences Inc., Lexeo Therapeutics, Spark Therapeutics, Xalud Therapeutics, uniQure, Ultragenyx Pharmaceutical, Nanoscope Therapeutics, and others.

Cell and Gene Therapy Manufacturing Market

Cell and Gene Therapy Manufacturing Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cell and gene therapy manufacturing companies, including Lonza, Catalent, Inc., Thermo Fisher Scientific, Inc., Charles River Laboratories, WuXi AppTec, Merck KGaA, Takara Bio Inc., Oxford Biomedica PLC, Genezen, FUJIFILM Holdings Corporation, Nikon Corporation, The Discovery Labs LLC, RoslinCT, JRS Pharma, FinVector, Sarepta Therapeutics, Inc., BioCentriq, Andelyn Biosciences, ElevateBio, Anemocyte Srl, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.